Selvita to Release the Most Recent Results from Its Oncology Programs at the AACR Annual Meeting 2015
Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, will publish the most recent data f…
Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, will publish the most recent data f…
Selvita, the largest independent drug discovery company in Central and Eastern Europe, will present new data at poster s…
Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, received a GM…
Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has extended…
Polish biotechnology company Selvita, announced today the appointment of Dr. Mirosława Zydron to the position of Member…
Selvita, Polish biotechnology company engaged in the discovery and development of breakthrough medicines to treat CNS an…
Selvita S.A. has been ranked as the no.1 Rising Star within this year's contest of Deloitte Technology Fast 50 in Centra…
The largest Polish drug discovery company Selvita announced today it has entered into definitive agreements with investo…